Table 1. Baseline Characteristics according to the Presence of Specific Cardiomyopathy.
No CM (n=1119) | DCM (n=10) | HCM (n=17) | LVNC (n=40) | p value | |
---|---|---|---|---|---|
Age (yr) | 56±15 | 56±5 | 60±13 | 51±16*‡ | 0.097 |
Male | 793 (71) | 8 (80) | 13 (77) | 35 (88)* | 0.135 |
Body mass index (kg/m2) | 23.9±3.6 | 23.7±3.5 | 24.7±2.2 | 23.4±3.2 | 0.666 |
Hypertension | 462 (41) | 3 (30) | 10 (59) | 17 (43) | 0.444 |
Diabetes mellitus | 209 (19) | 3 (30) | 9 (52)* | 4 (10)‡ | 0.001 |
Dyslipidemia | 231 (21) | 1 (10) | 3 (18) | 10 (25) | 0.742 |
CAD | 182 (16) | 0 (0) | 2 (12) | 5 (13) | 0.464 |
CKD | 97 (9) | 3 (30)* | 2 (12) | 4 (10) | 0.124 |
Heart failure | 178 (16) | 6 (60)* | 8 (47) | 8 (20)†‡ | <0.001 |
Preserved EF | 129 (12) | 0 (0) | 8 (47)*† | 6 (15)‡ | <0.001 |
Reduced EF | 49 (4) | 6 (60)* | 0 (0)† | 2 (5)† | <0.001 |
CM, cardiomyopathy; DCM, dilated cardiomyopathy; HCM, hypertrophic cardiomyopathy; LVNC, left ventricular non-compaction; CAD, coronary artery disease; CKD, chronic kidney disease; EF, ejection fraction.
Values are presented as mean±standard deviation or n (%) unless otherwise indicated.
*p<0.05 compared to the group with no CM; †p<0.05 compared to the DCM group; ‡p<0.05 compared to the HCM group.